tert-Butyl ((1-nicotinoylpiperidin-4-yl)methyl)carbamate

Catalog No. :
ACVJAL103
CAS No. :
1286273-25-3
Molecular Formula :
C17H25N3O3
Molecular Weight :
319.40

IUPAC Name:tert-butyl ((1-nicotinoylpiperidin-4-yl)methyl)carbamate

tert-Butyl ((1-nicotinoylpiperidin-4-yl)methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$369.00Login to see priceInquiryInquiry
250mg95%$640.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1-nicotinoylpiperidin-4-yl)methyl)carbamate
IUPAC Nametert-butyl ((1-nicotinoylpiperidin-4-yl)methyl)carbamate
MDL No.MFCD18378210
Molecular FormulaC17H25N3O3
Molecular Weight319.40
SMILESO=C(OC(C)(C)C)NCC1CCN(C(C2=CN=CC=C2)=O)CC1
InChI KeyIWQNBSWBNVIYSU-UHFFFAOYSA-N
Synonymtert-Butyl [(1-nicotinoylpiperidin-4-yl)methyl]carbamate;Carbamic acid, N-[[1-(3-pyridinylcarbonyl)-4-piperidinyl]methyl]-, 1,1-dimethylethyl ester
CAS No.1286273-25-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVJAL103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKBE041 route compound structure diagram
    ACNKBE041135632-53-0 In Stock
  2. Plus
  3. ACIGKT215 route compound structure diagram
    ACIGKT21559-67-6 In Stock
  4. Then
  5. ACVJAL103 route product structure diagram
    ACVJAL1031286273-25-3
Inquiry

2. ACVJAL103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKBE041 route compound structure diagram
    ACNKBE041135632-53-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVJAL103 route product structure diagram
    ACVJAL1031286273-25-3
Inquiry

Comments (0)